Pregled bibliografske jedinice broj: 1074110
Good Manufacturing Practice: The Role of Local Manufacturers and Competent Authorities
Good Manufacturing Practice: The Role of Local Manufacturers and Competent Authorities // Archives of Industrial Hygiene and Toxicology, 61 (2010), 4; 425-436 doi:10.2478/10004-1254-61-2010-2035 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1074110 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Good Manufacturing Practice: The Role of Local Manufacturers and Competent Authorities
Autori
Tomić, Siniša ; Sučić, Anita ; Martinac, Adrijana
Izvornik
Archives of Industrial Hygiene and Toxicology (0004-1254) 61
(2010), 4;
425-436
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
inspection ; medicinal product ; production ; quality assurance ; quality control ; qualified person
Sažetak
In every country, a manufacturer of medicinal products for either human or veterinary use is required to operate in compliance with local legislation effect that they are committed to abide by the same standards. The candidate countries transpose the acquis into their national legislation, including the good manufacturing practice (GMP). Consequently, the local manufacturer is required to strictly comply with GMP and the manufacturing licence, including for medicinal products exclusively intended for export. A vital role is also played by national regulatory authorities, in Croatia by the Agency for Medicinal Products and Medical Devices which issues the manufacturing licence, GMP certifi cate, and the Certifi cate of a Pharmaceutical Product (CPP) and conducts laboratory control of products. GMP inspection is carried out by the Pharmaceutical Inspectorate with the Ministry of Health and Social Welfare. Both authorities are responsible only for human medicines. There are legislative issues not yet harmonised with the acquis, but as a country aspiring for the EU membership, Croatia is expected to demonstrate that its industry and competent authorities are able to conform to current requirements and thus fully adhere to the integrated European regulatory network. Hence the importance of strengthening the institutional capacity of the competent authorities, as insuffi cient resources may have a direct bearing on patients by limiting their access to affordable treatment.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE